1887

Abstract

Gene transfer with recombinant adenoviruses (rAds) is a powerful means of inducing an immune response against a transgene product. However, little is known about the mechanisms that underlie the induction of the immune response after intramuscular inoculation of adenovirus and, in particular, the relative role of the different cell types transduced. Several studies have suggested that CD8 cytotoxic T lymphocyte responses elicited after inoculation of adenoviruses (Ads) are induced both by direct transduction of antigen presenting cells (APCs) and by cross-priming. In the present study, a library of fibre-chimeric rAds was screened in order to identify rAds with distinct capacities to express transgene product in murine cell types naturally found in muscle, i.e. myoblasts, endothelial cells (both representing non-APCs) and dendritic cells (representing APCs). Four selected pseudotypes, differing in their ability to infect muscular cells were used to immunize C57BL/6 mice. The relationship between the capacity to transduce non-APC or APC and the ability to induce humoral and cellular responses against the -galactosidase antigen after intramuscular inoculation were studied. Results indicate that CD8 T cell responses against the -galactosidase antigen were similar after inoculation of the four viruses, thus revealing no direct relationship with their ability to transduce myoblasts, endothelial cells or dendritic cells .

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.79846-0
2004-05-01
2019-11-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/5/vir851227.html?itemId=/content/journal/jgv/10.1099/vir.0.79846-0&mimeType=html&fmt=ahah

References

  1. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. & Palucka, K. ( 2000; ). Immunobiology of dendritic cells. Annu Rev Immunol 18, 767–811.[CrossRef]
    [Google Scholar]
  2. Barnett, B. G., Crews, C. J. & Douglas, J. T. ( 2002; ). Targeted adenoviral vectors. Biochim Biophys Acta 1575, 1–14.[CrossRef]
    [Google Scholar]
  3. Barry, M. & Bleackley, R. C. ( 2002; ). Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2, 401–409.
    [Google Scholar]
  4. Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L. & Finberg, R. W. ( 1997; ). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320–1323.[CrossRef]
    [Google Scholar]
  5. Brandao, J. G., Scheper, R. J., Lougheed, S. M. & 7 other authors ( 2003; ). CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation. Vaccine 21, 2268–2272.[CrossRef]
    [Google Scholar]
  6. Branger, C., Sonrier, C., Chatrenet, B., Klonjkowski, B., Ruvoen-Clouet, N., Aubert, A., Andre-Fontaine, G. & Eloit, M. ( 2001; ). Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun 69, 6831–6838.[CrossRef]
    [Google Scholar]
  7. Dai, Y., Schwarz, E. M., Gu, D., Zhang, W. W., Sarvetnick, N. & Verma, I. M. ( 1995; ). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci U S A 92, 1401–1405.[CrossRef]
    [Google Scholar]
  8. De Jong, J. C., Wermenbol, A. G., Verweij-Uijterwaal, M. W., Slaterus, K. W., Wertheim-Van Dillen, P., Van Doornum, G. J., Khoo, S. H. & Hierholzer, J. C. ( 1999; ). Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol 37, 3940–3945.
    [Google Scholar]
  9. Einfeld, D. A., Schroeder, R., Roelvink, P. W., Lizonova, A., King, C. R., Kovesdi, I. & Wickham, T. J. ( 2001; ). Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions. J Virol 75, 11284–11291.[CrossRef]
    [Google Scholar]
  10. Fontana, L., Nuzzo, M., Urbanelli, L. & Monaci, P. ( 2003; ). General strategy for broadening adenovirus tropism. J Virol 77, 11094–11104.[CrossRef]
    [Google Scholar]
  11. Gromme, M. & Neefjes, J. ( 2002; ). Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol 39, 181–202.[CrossRef]
    [Google Scholar]
  12. Havenga, M. J., Lemckert, A. A., Grimbergen, J. M., Vogels, R., Huisman, L. G., Valerio, D., Bout, A. & Quax, P. H. ( 2001; ). Improved adenovirus vectors for infection of cardiovascular tissues. J Virol 75, 3335–3342.[CrossRef]
    [Google Scholar]
  13. Heath, W. R. & Carbone, F. R. ( 2001; ). Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 1, 126–134.[CrossRef]
    [Google Scholar]
  14. Hong, S. S., Bardy, M., Monteil, M., Gay, B., Denesvre, C., Tournier, J., Martin, G., Eloit, M. & Boulanger, P. ( 2000; ). Immunoreactive domains and integrin-binding motifs in adenovirus penton base capsomer. Viral Immunol 13, 353–371.[CrossRef]
    [Google Scholar]
  15. Horwitz, M. S. ( 1996; ). Adenoviruses. In Virology, 3rd edn, vol. 2, pp. 2149–2171. Edited by B. N. Fields, D. N. Knipe & P. M. Howley. Philadelphia: Lippincott–Raven.
  16. Huard, J., Lochmuller, H., Acsadi, G., Jani, A., Holland, P., Guerin, C., Massie, B. & Karpati, G. ( 1995; ). Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants. Exp Mol Pathol 62, 131–143.[CrossRef]
    [Google Scholar]
  17. Jooss, K., Yang, Y., Fisher, K. J. & Wilson, J. M. ( 1998; ). Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 72, 4212–4223.
    [Google Scholar]
  18. Juillard, V., Villefroy, P., Godfrin, D., Pavirani, A., Venet, A. & Guillet, J. G. ( 1995; ). Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur J Immunol 25, 3467–3473.[CrossRef]
    [Google Scholar]
  19. Klonjkowski, B., Denesvre, C. & Eloit, M. ( 1999; ). Adenoviral vectors for vaccines. In Adenoviruses: Basic Biology to Gene Therapy, pp. 163–173. Edited by P. Seth. Austin, TX: R. G. Landes.
  20. Kurts, C., Miller, J. F., Subramaniam, R. M., Carbone, F. R. & Heath, W. R. ( 1998; ). Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med 188, 409–414.[CrossRef]
    [Google Scholar]
  21. Lemarchand, P., Jaffe, H. A., Danel, C. & 7 other authors ( 1992; ). Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci U S A 89, 6482–6486.[CrossRef]
    [Google Scholar]
  22. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N. & Schuler, G. ( 1999; ). An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223, 77–92.[CrossRef]
    [Google Scholar]
  23. Marelli-Berg, F. M., Scott, D., Bartok, I., Peek, E., Dyson, J. & Lechler, R. I. ( 2000; ). Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells: a mechanism of immunoregulation? J Immunol 165, 4182–4189.[CrossRef]
    [Google Scholar]
  24. Marelli-Berg, F. M., Scott, D., Bartok, I., Peek, E., Dyson, J. & Lechler, R. I. ( 2001; ). Antigen presentation by murine endothelial cells. Transplant Proc 33, 315–316.[CrossRef]
    [Google Scholar]
  25. Mercier, S., Gahery-Segard, H., Monteil, M., Lengagne, R., Guillet, J. G., Eloit, M. & Denesvre, C. ( 2002; ). Distinct roles of adenovirus vector-transduced dendritic cells, myoblasts, and endothelial cells in mediating an immune response against a transgene product. J Virol 76, 2899–2911.[CrossRef]
    [Google Scholar]
  26. Oukka, M., Cohen-Tannoudji, M., Tanaka, Y., Babinet, C. & Kosmatopoulos, K. ( 1996; ). Medullary thymic epithelial cells induce tolerance to intracellular proteins. J Immunol 156, 968–975.
    [Google Scholar]
  27. Quantin, B., Perricaudet, L. D., Tajbakhsh, S. & Mandel, J. L. ( 1992; ). Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci U S A 89, 2581–2584.[CrossRef]
    [Google Scholar]
  28. Ramirez, M. C. & Sigal, L. J. ( 2002; ). Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J Immunol 169, 6733–6742.[CrossRef]
    [Google Scholar]
  29. Rea, D., Havenga, M. J., van Den Assem, M., Sutmuller, R. P., Lemckert, A., Hoeben, R. C., Bout, A., Melief, C. J. & Offringa, R. ( 2001; ). Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol 166, 5236–5244.[CrossRef]
    [Google Scholar]
  30. Sakurai, F., Mizuguchi, H., Yamaguchi, T. & Hayakawa, T. ( 2003; ). Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector. Mol Ther 8, 813–821.[CrossRef]
    [Google Scholar]
  31. Sarukhan, A., Camugli, S., Gjata, B., von Boehmer, H., Danos, O. & Jooss, K. ( 2001; ). Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol 75, 269–277.[CrossRef]
    [Google Scholar]
  32. Segerman, A., Arnberg, N., Erikson, A., Lindman, K. & Wadell, G. ( 2003a; ). There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses. J Virol 77, 1157–1162.[CrossRef]
    [Google Scholar]
  33. Segerman, A., Atkinson, J. P., Martilla, M., Dennerquist, V., Wadell, G. & Arnberg, N. ( 2003b; ). Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 77, 9183–9191.[CrossRef]
    [Google Scholar]
  34. Shabram, P. W., Giroux, D. D., Goudreau, A. M. & 7 other authors ( 1997; ). Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum Gene Ther 8, 453–465.[CrossRef]
    [Google Scholar]
  35. Shen, X., Wong, S. B., Buck, C. B., Zhang, J. & Siliciano, R. F. ( 2002; ). Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes. J Immunol 169, 4222–4229.[CrossRef]
    [Google Scholar]
  36. Shiver, J. W., Fu, T. M., Chen, L. & 49 other authors ( 2002; ). Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331–335.[CrossRef]
    [Google Scholar]
  37. Spiller, O. B., Goodfellow, I. G., Evans, D. J., Hinchliffe, S. J. & Morgan, B. P. ( 2002; ). Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR do not use pig DAF. J Gen Virol 83, 45–52.
    [Google Scholar]
  38. Timares, L., Takashima, A. & Johnston, S. A. ( 1998; ). Quantitative analysis of the immunopotency of genetically transfected dendritic cells. Proc Natl Acad Sci U S A 95, 13147–13152.[CrossRef]
    [Google Scholar]
  39. Tomko, R. P., Xu, R. & Philipson, L. ( 1997; ). HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 94, 3352–3356.[CrossRef]
    [Google Scholar]
  40. Tripathy, S. K., Black, H. B., Goldwasser, E. & Leiden, J. M. ( 1996; ). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2, 545–550.[CrossRef]
    [Google Scholar]
  41. van Deutekom, J. C., Cao, B., Pruchnic, R., Wickham, T. J., Kovesdi, I. & Huard, J. ( 1999; ). Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle. J Gene Med 1, 393–399.[CrossRef]
    [Google Scholar]
  42. Vicart, P., Schwartz, B., Vandewalle, A., Bens, M., Delouis, C., Panthier, J. J., Pournin, S., Babinet, C. & Paulin, D. ( 1994; ). Immortalization of multiple cell types from transgenic mice using a transgene containing the vimentin promoter and a conditional oncogene. Exp Cell Res 214, 35–45.[CrossRef]
    [Google Scholar]
  43. Wang, X., Messerle, M., Sapinoro, R., Santos, K., Hocknell, P. K., Jin, X. & Dewhurst, S. ( 2003; ). Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J Virol 77, 7182–7192.[CrossRef]
    [Google Scholar]
  44. Wickham, T. J., Mathias, P., Cheresh, D. A. & Nemerow, G. R. ( 1993; ). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73, 309–319.[CrossRef]
    [Google Scholar]
  45. Wickham, T. J., Tzeng, E., Shears, L. L., II, Roelvink, P. W., Li, Y., Lee, G. M., Brough, D. E., Lizonova, A. & Kovesdi, I. ( 1997; ). Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 71, 8221–8229.
    [Google Scholar]
  46. Yang, Y., Haecker, S. E., Su, Q. & Wilson, J. M. ( 1996; ). Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 5, 1703–1712.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.79846-0
Loading
/content/journal/jgv/10.1099/vir.0.79846-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error